Fundamental Analysis of Lotus Eye Hospital & Institute Ltd

Share Price and Basic Stock Data

Last Updated: September 6, 2024, 11:33 pm

Market Cap	162 Cr.
Current Price	77.5
High / Low	111/44.1
Stock P/E	75.2
Book Value	28.6
Dividend Yield	0.65 %
ROCE	7.07 %
ROE	4.97 %
Face Value	10.0
PEG Ratio	2.46

Data Source: screener.in

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

Competitors of Lotus Eye Hospital & Institute Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Global Longlife Hospital and Research Ltd	44.4 Cr.	42.3	61.7/27.0		24.7	0.00 %	2.04 %	3.41 %	10.0
Gian Lifecare Ltd	22.9 Cr.	22.2	29.0/18.5	5.53	19.0	0.00 %	29.1 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	113 Cr.	60.1	108/44.0		58.4	70.7 %	3.29 %	9.12 %	10.0
Family Care Hospitals Ltd	40.3 Cr.	7.46	10.4/6.23	3.60	10.8	0.67 %	15.2 %	24.1 %	10.0
Dr Lalchandani Labs Ltd	9.32 Cr.	21.5	35.0/15.7	15.0	22.0	0.00 %	6.53 %	6.95 %	10.0
Industry Average	26,974.50 Cr	830.75		54.61	90.15	3.66%	11.76%	11.81%	9.38

Lotus Eye Hospital & Institute Ltd Quarterly Results

Month	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Sales	9.87	10.57	5.92	10.81	11.61	10.57	11.87	11.86	12.14	11.17	12.57	12.73	12.03
Expenses	8.20	8.81	5.75	8.72	9.26	9.33	9.55	10.10	10.03	9.78	10.18	10.92	10.45
Operating Profit	1.67	1.76	0.17	2.09	2.35	1.24	2.32	1.76	2.11	1.39	2.39	1.81	1.58
OPM %	16.92%	16.65%	2.87%	19.33%	20.24%	11.73%	19.55%	14.84%	17.38%	12.44%	19.01%	14.22%	13.13%
Other Income	0.20	0.19	0.17	0.21	0.22	0.28	0.24	0.23	0.32	0.36	0.29	0.28	0.34
Interest	0.02	0.01	0.02	0.04	0.04	0.03	0.03	0.03	0.02	0.02	0.02	0.01	0.04
Depreciation	0.59	0.59	0.53	0.60	0.63	0.75	0.68	0.75	0.77	0.78	0.73	0.89	0.98
Profit before tax	1.26	1.35	-0.21	1.66	1.90	0.74	1.85	1.21	1.64	0.95	1.93	1.19	0.90
Tax %	15.87%	17.78%	4.76%	24.70%	26.84%	27.03%	26.49%	24.79%	29.88%	31.58%	27.98%	28.57%	26.67%
Net Profit	1.05	1.11	-0.20	1.25	1.39	0.54	1.37	0.90	1.16	0.65	1.38	0.85	0.66
EPS in Rs	0.50	0.53	-0.10	0.60	0.67	0.26	0.66	0.43	0.56	0.31	0.66	0.41	0.32

Last Updated: July 12, 2024, 11:35 am

Quarterly Chart

Lotus Eye Hospital & Institute Ltd Profit & Loss

Last Updated: July 10, 2024, 7:20 pm

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Sales	26.23	29.11	28.69	29.90	31.13	33.96	38.02	38.43	40.55	32.35	38.90	47.03	48.61
Expenses	24.64	25.51	25.40	27.72	27.14	30.63	33.68	35.21	36.57	28.73	32.98	39.35	40.91
Operating Profit	1.59	3.60	3.29	2.18	3.99	3.33	4.34	3.22	3.98	3.62	5.92	7.68	7.70
OPM %	6.06%	12.37%	11.47%	7.29%	12.82%	9.81%	11.42%	8.38%	9.82%	11.19%	15.22%	16.33%	15.84%
Other Income	0.36	0.64	0.39	0.46	0.58	0.68	0.91	0.68	0.21	0.84	0.88	1.15	1.25
Interest	0.05	0.05	0.04	0.10	0.16	0.15	0.18	0.21	0.24	0.14	0.21	0.20	0.07
Depreciation	4.14	3.73	3.54	4.76	4.44	3.44	3.37	3.06	2.50	2.33	2.50	2.98	3.17
Profit before tax	-2.24	0.46	0.10	-2.22	-0.03	0.42	1.70	0.63	1.45	1.99	4.09	5.65	5.71
Tax %	-0.45%	8.70%	60.00%	10.81%	400.00%	-7.14%	-2.35%	-12.70%	26.90%	21.11%	27.14%	27.79%
Net Profit	-2.25	0.42	0.04	-1.98	0.10	0.44	1.75	0.71	1.06	1.57	2.98	4.08	4.04
EPS in Rs	-1.08	0.20	0.02	-0.95	0.05	0.21	0.84	0.34	0.51	0.75	1.43	1.96	1.94
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	236.36%	59.43%	0.00%	0.00%	66.24%	34.90%	25.49%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2012-2013	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023
YoY Net Profit Growth (%)	118.67%	-90.48%	-5050.00%	105.05%	340.00%	297.73%	-59.43%	49.30%	48.11%	89.81%	36.91%
Change in YoY Net Profit Growth (%)	0.00%	-209.14%	-4959.52%	5155.05%	234.95%	-42.27%	-357.16%	108.72%	-1.18%	41.70%	-52.90%

Lotus Eye Hospital & Institute Ltd Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	5%
3 Years:	14%
TTM:	3%

Compounded Profit Growth
10 Years:	54%
5 Years:	33%
3 Years:	24%
TTM:	-29%

Stock Price CAGR
10 Years:	21%
5 Years:	28%
3 Years:	11%
1 Year:	-30%

Return on Equity
10 Years:	3%
5 Years:	5%
3 Years:	6%
Last Year:	5%

Last Updated: July 19, 2024, 5:25 pm

Lotus Eye Hospital & Institute Ltd Balance Sheet

Last Updated: July 10, 2024, 7:20 pm

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80
Reserves	30.11	30.53	30.57	28.59	28.69	29.26	29.84	29.32	30.46	31.90	33.81	36.78	37.95
Borrowings	0.43	0.26	0.18	0.83	0.66	0.48	0.29	0.22	0.32	0.40	1.24	0.67	0.00
Other Liabilities	4.72	5.31	7.01	6.20	4.68	4.40	7.28	6.18	6.53	6.12	5.75	4.93	8.06
Total Liabilities	56.06	56.90	58.56	56.42	54.83	54.94	58.21	56.52	58.11	59.22	61.60	63.18	66.81
Fixed Assets	47.78	45.31	46.94	47.04	43.57	41.32	42.52	44.14	42.67	40.54	44.07	44.18	46.99
CWIP	0.00	0.18	0.36	0.27	0.42	0.65	0.29	0.29	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	8.28	11.41	11.26	9.11	10.84	12.97	15.40	12.09	15.44	18.68	17.53	19.00	19.82
Total Assets	56.06	56.90	58.56	56.42	54.83	54.94	58.21	56.52	58.11	59.22	61.60	63.18	66.81

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	3.71	4.41	2.37	3.38	2.97	5.78	4.20	4.97	2.73	4.41	4.39	5.68
Cash from Investing Activity	-1.20	-5.05	-4.65	-0.85	-1.06	-3.86	-4.01	-0.68	0.49	-3.94	-2.19	-4.63
Cash from Financing Activity	-0.16	-0.77	1.87	-0.58	-0.25	-1.51	-1.41	0.13	-0.32	-1.58	-1.71	-3.40
Net Cash Flow	2.35	-1.41	-0.40	1.96	1.66	0.41	-1.22	4.42	2.90	-1.10	0.49	-2.35

Free Cash Flow

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Free Cash Flow	1.59	3.34	3.11	1.35	3.33	2.85	4.05	3.00	3.66	3.22	4.68	7.01

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	3.89	4.96	4.27	5.98	7.31	10.94	7.22	5.94	8.35	5.82	9.08	9.54
Inventory Days	135.42	166.70	121.54	113.25	60.22	79.23	128.20	124.42	138.82	150.03	153.60	170.30
Days Payable	160.79	130.52	125.08	105.51	87.32	129.95	167.37	170.41	220.72	231.21	173.42	183.56
Cash Conversion Cycle	-21.48	41.14	0.73	13.72	-19.79	-39.78	-31.95	-40.05	-73.54	-75.37	-10.74	-3.72
Working Capital Days	0.25	-13.10	-19.90	-8.56	-8.92	-26.02	-14.53	-21.33	-20.99	-10.98	12.34	8.86
ROCE %	0.99%	0.27%	-4.23%	0.24%	1.19%	3.63%	1.66%	4.67%	3.92%	7.91%	10.25%	7.07%

Financial Efficiency Indicators Chart

Lotus Eye Hospital & Institute Ltd Share Holding Pattern

Month	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Promoters	57.74%	57.74%	57.74%	57.74%	57.74%	57.74%	57.88%	58.14%	58.17%	58.44%	57.58%	56.58%
Public	42.26%	42.26%	42.26%	42.26%	42.26%	42.26%	42.12%	41.86%	41.83%	41.56%	42.43%	43.42%
No. of Shareholders	5,963	6,330	6,175	6,226	6,830	7,031	7,416	7,416	7,345	7,425	7,660	8,314

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	1.40	1.96	1.44	0.75	0.51
Diluted EPS (Rs.)	1.40	1.96	1.44	0.75	0.51
Cash EPS (Rs.)	3.19	3.39	2.64	1.87	1.71
Book Value[Excl.RevalReserv]/Share (Rs.)	28.57	27.69	26.26	25.34	24.65
Book Value[Incl.RevalReserv]/Share (Rs.)	28.57	27.69	26.26	25.34	24.65
Dividend / Share (Rs.)	0.00	0.50	0.50	0.50	0.00
Revenue From Operations / Share (Rs.)	23.18	22.62	18.71	15.56	19.50
PBDIT / Share (Rs.)	3.77	4.20	3.24	2.07	2.27
PBIT / Share (Rs.)	1.97	2.77	2.03	0.95	1.07
PBT / Share (Rs.)	1.93	2.72	1.97	0.95	0.69
Net Profit / Share (Rs.)	1.40	1.96	1.44	0.75	0.51
PBDIT Margin (%)	16.24	18.56	17.30	13.30	11.62
PBIT Margin (%)	8.51	12.22	10.87	6.10	5.47
PBT Margin (%)	8.32	12.01	10.52	6.15	3.58
Net Profit Margin (%)	6.04	8.66	7.67	4.84	2.62
Return on Networth / Equity (%)	4.90	7.08	5.46	2.97	2.07
Return on Capital Employeed (%)	6.79	9.91	7.57	3.69	4.23
Return On Assets (%)	4.37	6.45	4.84	2.64	1.82
Asset Turnover Ratio (%)	0.74	0.75	0.64	0.55	0.70
Current Ratio (X)	2.25	2.83	2.24	2.34	1.75
Quick Ratio (X)	1.74	2.30	1.84	2.03	1.41
Inventory Turnover Ratio (X)	2.81	3.28	3.19	2.61	2.66
Interest Coverage Ratio (X)	80.42	89.47	52.56	66.35	66.88
Interest Coverage Ratio (Post Tax) (X)	30.86	42.80	24.38	23.91	25.92
Enterprise Value (Cr.)	110.46	112.37	102.10	77.22	41.44
EV / Net Operating Revenue (X)	2.29	2.39	2.62	2.39	1.02
EV / EBITDA (X)	14.10	12.87	15.17	17.93	8.79
MarketCap / Net Operating Revenue (X)	2.44	2.57	2.85	2.69	1.19
Price / BV (X)	1.98	2.10	2.03	1.65	0.94
Price / Net Operating Revenue (X)	2.44	2.57	2.85	2.69	1.19
EarningsYield	0.02	0.03	0.02	0.01	0.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: ₹107.59

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 38.83% compared to the current price ₹77.50

Intrinsic Value: 140.55

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 81.35% compared to the current price ₹77.50

Last 5 Year EPS CAGR: 30.63%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -10.24, which is a positive sign. The stock has a low average Cash Conversion Cycle of -21.74, which is a positive sign. The company has higher reserves (31.53 cr) compared to borrowings (0.56 cr), indicating strong financial stability. The company has shown consistent growth in sales (35.61 cr) and profit (1.36 cr) over the years.	The stock has a low average ROCE of 3.13%, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lotus Eye Hospital & Institute Ltd:
1. Net Profit Margin: 6.04%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 6.79% (Industry Average ROCE: 11.76%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.9% (Industry Average ROE: 11.81%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 30.86
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.74
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 75.2 (Industry average Stock P/E: 54.61)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783. Currently company belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 38.91 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	S.F No.770/12, Avinashi Road, Coimbatore Tamil Nadu 641014	companysecretary@lotuseye.org http://www.lotuseye.org

Management
Name	Position Held
Dr. Kavetha Sundaramoorthy	Chairman
Ms. Sangeetha Sundaramoorthy	Managing Director
Dr. K S Ramalingam	WholeTime Director & CEO
Dr. S Natesan	Director
CA. Perumalsamy Mahendran	Director
CA. M Alagiriswamy	Director
Mr. Karthik Veeramani	Director
Mr. D R Kaarthikeyan	Director
Dr. Yogesh Shah	Director

FAQ

What is the latest fair value of Lotus Eye Hospital & Institute Ltd?

The latest fair value of Lotus Eye Hospital & Institute Ltd is ₹107.59.

What is the Market Cap of Lotus Eye Hospital & Institute Ltd?

The Market Cap of Lotus Eye Hospital & Institute Ltd is 162 Cr..

What is the current Stock Price of Lotus Eye Hospital & Institute Ltd as on 08 September 2024?

The current stock price of Lotus Eye Hospital & Institute Ltd as on 08 September 2024 is 77.5.

What is the High / Low of Lotus Eye Hospital & Institute Ltd stocks in FY 2024?

In FY 2024, the High / Low of Lotus Eye Hospital & Institute Ltd stocks is 111/44.1.

What is the Stock P/E of Lotus Eye Hospital & Institute Ltd?

The Stock P/E of Lotus Eye Hospital & Institute Ltd is 75.2.

What is the Book Value of Lotus Eye Hospital & Institute Ltd?

The Book Value of Lotus Eye Hospital & Institute Ltd is 28.6.

What is the Dividend Yield of Lotus Eye Hospital & Institute Ltd?

The Dividend Yield of Lotus Eye Hospital & Institute Ltd is 0.65 %.

What is the ROCE of Lotus Eye Hospital & Institute Ltd?

The ROCE of Lotus Eye Hospital & Institute Ltd is 7.07 %.

What is the ROE of Lotus Eye Hospital & Institute Ltd?

The ROE of Lotus Eye Hospital & Institute Ltd is 4.97 %.

What is the Face Value of Lotus Eye Hospital & Institute Ltd?

The Face Value of Lotus Eye Hospital & Institute Ltd is 10.0.